Haoyuan pharmaceutical: it plans to purchase 100% equity shares of drug source drugs and suspend trading
Haoyuan pharmaceutical announced that the company plans to acquire 100% equity of drug source drugs held by Wang Yuan, Shanghai Yuanmeng enterprise management consulting partnership (limited partnership), Qidong Yuanli enterprise management consulting partnership (limited partnership) and Ningbo Jiusheng innovative pharmaceutical technology Co., Ltd. by issuing shares and paying cash, At the same time, it is proposed to issue shares to the controlling shareholder of the company, Shanghai Anshu Information Technology Co., Ltd., to raise supporting funds of no more than 50 million yuan. The trading of the company's shares has been suspended since February 21, and the suspension is expected to be no more than 10 trading days.
This text is a result of machine translation.
Related companies：
In-depth
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Nov 08, 2022 08:32 AM
Technology
Semiconductor Company iSABers materials Completes Over $220 Million Series A++ Financing
iSABers materials (Chinese: 青禾晶元), a semiconductor materials bonding and integration technology company, announced that it has completed a Series A++ financing round totaling RMB 220 million.
May 27, 2023 12:59 AM
Technology
Wisson Tech Releases Draco MH3000 Flexible Composite Robot
Wisson Tech(Chinese: 万勋科技), a provider of interactive service robotics solutions, recently announced the Draco MH3000 flexible composite robot, based on its proprietary flexible robotics technology (Pliabot).
May 26, 2023 11:14 PM
Briefing Dec 15, 2021 02:09 PM
· Consumer Discretionary
Huawei announces vehicle traffic command patent
Technology
Chinese Internet Tech Firm NetEase’s Revenue Rises 6.3% YoY, Reaching CNY 25 Bn in Q1 2023
NetEase continues to invest in self-research key technologies such as AI big models this quarter, with R&D investment of CNY 3.7 billion, accounting for 15% of the total revenue.
May 26, 2023 04:07 PM
Briefing Nov 30, 2021 08:39 PM
· Consumer Discretionary
Guanglian Airlines: Lu Yan, the shareholder, plans to reduce his shares by no more than 2.24%
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary, Industrials, Consumer Staples · Analysis
TOPS in Shanghai: The New Trends in the Pet Industry's Overseas Expansion
May 12, 2023 01:33 PM